Literature DB >> 23912333

Neutrophil chemotaxis caused by chronic obstructive pulmonary disease alveolar macrophages: the role of CXCL8 and the receptors CXCR1/CXCR2.

Manminder Kaur1, Dave Singh.   

Abstract

Alveolar macrophages produce neutrophil chemoattractants; this cellular cross-talk contributes to neutrophilic airway inflammation in chronic obstructive pulmonary disease (COPD). We have investigated the chemotaxis cross-talk mechanisms between these cells using COPD alveolar macrophages. Using conditioned media from stimulated COPD alveolar macrophages, we investigated the relative contributions of growth-related oncogene (CXCL1), interleukin-8 (CXCL8), and regulated on activation normal T cell expressed and secreted (CCL5) to neutrophil chemotaxis and evaluated the effect of blocking the chemokine receptors CXCR1 and CXCR2 on chemotaxis caused by macrophage-conditioned media. Furthermore, we evaluated whether corticosteroid treatment of stimulated alveolar macrophages inhibited the chemotaxis ability of conditioned media. Alveolar macrophages isolated from COPD (n = 8) and smoker (S) (n = 8) lungs were treated with ultra-pure lipopolysaccharide in the presence and absence of dexamethasone (1 μM). Supernatants were used for neutrophil chemotaxis assays. SB656933 (2-hydroxy-N,N-dimethyl-3-{2-[[(R)-1-(5-methyl-furan-2-yl)-propyl]amino]-3,4-dioxo-cyclobut-1-enylamino}-benzamide) (CXCR2 antagonist) and Sch527123 [1-(2-chloro-3-fluorophenyl)-3-(4-chloro-2-hydroxy-3-piperazin-1-ylsulfonylphenyl)urea, 3-(2-chloro-3-fluoro-phenyl)-1-(4-chloro-2-hydroxy-3-piperazin-1-ylsulfonyl-phenyl)urea] (dual CXCR1 and CXCR2 antagonist) and blocking antibodies for CXCL8, CXCL1, and CCL5 were assessed. Conditioned media caused neutrophil chemotaxis in COPD and smokers (60.5 and 79.9% of total cells, respectively). Dexamethasone did not significantly reduce neutrophil chemotaxis in COPD or S. SB656933 and Sch527123 inhibited chemotaxis in a concentration-dependent manner, with the dual antagonist Sch527123 causing greater inhibition of chemotaxis. CXCL8 antibody inhibited neutrophil chemotaxis to basal levels, although there was no significant effect of blocking either CXCL1 or CCL5 (P > 0.05). CXCL8 plays a major role in neutrophil chemotaxis caused by alveolar macrophage-derived conditioned media, and this is most effectively inhibited by dual antagonism of CXCR1 and CXCR2. Corticosteroids do not inhibit chemotaxis caused by macrophage-derived chemokines.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23912333     DOI: 10.1124/jpet.112.201855

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  28 in total

1.  Air pollution particulate matter alters antimycobacterial respiratory epithelium innate immunity.

Authors:  César E Rivas-Santiago; Srijata Sarkar; Pasquale Cantarella; Álvaro Osornio-Vargas; Raúl Quintana-Belmares; Qingyu Meng; Thomas J Kirn; Pamela Ohman Strickland; Judith C Chow; John G Watson; Martha Torres; Stephan Schwander
Journal:  Infect Immun       Date:  2015-04-06       Impact factor: 3.441

2.  Deficiency of the two-pore-domain potassium channel TREK-1 promotes hyperoxia-induced lung injury.

Authors:  Andreas Schwingshackl; Bin Teng; Patrudu Makena; Manik Ghosh; Scott E Sinclair; Charlean Luellen; Louisa Balasz; Cynthia Rovnaghi; Robert M Bryan; Eric E Lloyd; Elizabeth Fitzpatrick; Jordy S Saravia; Stephania A Cormier; Christopher M Waters
Journal:  Crit Care Med       Date:  2014-11       Impact factor: 7.598

Review 3.  Modulation of Host Immunity by the Human Metapneumovirus.

Authors:  Pablo F Céspedes; Christian E Palavecino; Alexis M Kalergis; Susan M Bueno
Journal:  Clin Microbiol Rev       Date:  2016-10       Impact factor: 26.132

Review 4.  The Dynamic Contribution of Neutrophils in the Chronic Respiratory Diseases.

Authors:  Jongho Ham; Jihyun Kim; Young Gyun Ko; Hye Young Kim
Journal:  Allergy Asthma Immunol Res       Date:  2022-07       Impact factor: 5.096

5.  In situ neutrophil efferocytosis shapes T cell immunity to influenza infection.

Authors:  Kihong Lim; Tae-Hyoun Kim; Alissa Trzeciak; Andrea M Amitrano; Emma C Reilly; Hen Prizant; Deborah J Fowell; David J Topham; Minsoo Kim
Journal:  Nat Immunol       Date:  2020-08-03       Impact factor: 25.606

6.  Acute Lung Injury in Response to Intratracheal Instillation of Lipopolysaccharide in an Animal Model of Emphysema Induced by Elastase.

Authors:  Maria Aparecida Esteves Rabelo; Leda Marília Fonseca Lucinda; Maycon Moura Reboredo; Lídia Maria Carneiro da Fonseca; Fernando Fonseca Reis; Thaís Fernanda Fazza; Danielle Ribeiro Brega; Flavia de Paoli; Adenilson de Souza da Fonseca; Bruno Valle Pinheiro
Journal:  Inflammation       Date:  2018-02       Impact factor: 4.092

7.  Selection of a picomolar antibody that targets CXCR2-mediated neutrophil activation and alleviates EAE symptoms.

Authors:  Xiaojie Shi; Yue Wan; Nan Wang; Jiangchao Xiang; Tao Wang; Xiaofeng Yang; Ju Wang; Xuxue Dong; Liang Dong; Lei Yan; Yu Li; Lili Liu; Shinchen Hou; Zhenwei Zhong; Ian A Wilson; Bei Yang; Guang Yang; Richard A Lerner
Journal:  Nat Commun       Date:  2021-05-05       Impact factor: 14.919

8.  The impact of ATRA on shaping human myeloid cell responses to epithelial cell-derived stimuli and on T-lymphocyte polarization.

Authors:  Arunima Chatterjee; Péter Gogolak; Hervé M Blottière; Éva Rajnavölgyi
Journal:  Mediators Inflamm       Date:  2015-04-07       Impact factor: 4.711

9.  The effects of corticosteroids on COPD lung macrophages: a pooled analysis.

Authors:  Andrew Higham; George Booth; Simon Lea; Thomas Southworth; Jonathan Plumb; Dave Singh
Journal:  Respir Res       Date:  2015-08-20

10.  S-maltoheptaose targets syndecan-bound effectors to reduce smoking-related neutrophilic inflammation.

Authors:  David C L Lam; Stanley C H Chan; Judith C W Mak; Craig Freeman; Mary S M Ip; Daisy K Y Shum
Journal:  Sci Rep       Date:  2015-08-10       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.